Wnt pathway antagonists and angiogenesis

Abstract

Dysregulation of the Wnt pathway has been extensively studied in multiple diseases, including some angiogenic disorders. Wnt signaling activation is a major stimulator in pathological angiogenesis and thus, Wnt antagonists are believed to have therapeutic potential for neovascular disorders. Actually, some Wnt antagonists have been identified directly from the anti-angiogenic factor family. This review summarizes the recent progress toward understanding of the roles of Wnt pathway antagonists in angiogenic regulation and their mechanism of action, and exploring their therapeutic potential.

Keywords

sFRPs / Dkk / WIF-1 / endostatin / SERPINA3K / curcumin

References

[1] Adams, B.K., Ferstl, E.M., Davis, M.C., Herold, M., Kurtkaya, S., Camalier, R.F., Hollingshead, M.G., Kaur, G., Sausville, E.A., Rickles, F.R., . (2004). Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem 12, 3871-3883 .10.1016/j.bmc.2004.05.006
[2] Arbiser, J.L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M.T., Fisher, C., Flynn, E., and Byers, H.R. (1998). Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4, 376-383 .
[3] Bányai, L., and Patthy, L. (1999). The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci 8, 1636-1642 .10.1110/ps.8.8.1636
[4] Behrens, J. (2000). Cross-regulation of the Wnt signalling pathway: a role of MAP kinases. J Cell Sci 113, 911-919 .
[5] Behrens, J., von Kries, J.P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642 .10.1038/382638a0
[6] Bhandarkar, S.S., and Arbiser, J.L. (2007). Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595, 185-195 .10.1007/978-0-387-46401-5_7
[7] Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. (1999). beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155, 1033-1038 .
[8] Brott, B.K., and Sokol, S.Y. (2002). Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22, 6100-6110 .10.1128/MCB.22.17.6100-6110.2002
[9] Chamorro, M.N., Schwartz, D.R., Vonica, A., Brivanlou, A.H., Cho, K.R., and Varmus, H.E. (2005). FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J 24, 73-84 .10.1038/sj.emboj.7600460
[10] Chao, J., Chai, K.X., Chen, L.M., Xiong, W., Chao, S., Woodley-Miller, C., Wang, L.X., Lu, H.S., and Chao, L. (1990). Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J Biol Chem 265, 16394-16401 .
[11] Chao, J., Tillman, D.M., Wang, M.Y., Margolius, H.S., and Chao, L. (1986). Identification of a new tissue-kallikrein-binding protein. Biochem J 239, 325-331 .
[12] Chen, Y., Hu, Y., Lu, K., Flannery, J.G., and Ma, J.X. (2007). Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem 282, 34420-34428 .10.1074/jbc.M611289200
[13] Chen, Y., Hu, Y., Zhou, T., Zhou, K.K., Mott, R., Wu, M., Boulton, M., Lyons, T.J., Gao, G., and Ma, J.X. (2009). Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175, 2676-2685 .10.2353/ajpath.2009.080945
[14] Cheng, C.W., Smith, S.K., and Charnock-Jones, D.S. (2003). Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology. Exp Cell Res 291, 415-425 .10.1016/j.yexcr.2003.07.006
[15] Clements, J.A. (1989). The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr Rev 10, 393-419 .10.1210/edrv-10-4-393
[16] Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480 .
[17] Conney, A.H., Lysz, T., Ferraro, T., Abidi, T.F., Manchand, P.S., Laskin, J.D., and Huang, M.T. (1991). Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31, 385-396 .10.1016/0065-2571(91)90025-H
[18] Dale, T.C. (1998). Signal transduction by the Wnt family of ligands. Biochem J 329, 209-223 .
[19] Dufourcq, P., Couffinhal, T., Ezan, J., Barandon, L., Moreau, C., Daret, D., and Duplàa, C. (2002). FrzA, a secreted frizzled related protein, induced angiogenic response. Circulation 106, 3097-3103 .10.1161/01.CIR.0000039342.85015.5C
[20] Duplàa, C., Jaspard, B., Moreau, C., and D’Amore, P.A. (1999). Identification and cloning of a secreted protein related to the cysteine-rich domain of frizzled. Evidence for a role in endothelial cell growth control. Circ Res 84, 1433-1445 .
[21] Easwaran, V., Lee, S.H., Inge, L., Guo, L., Goldbeck, C., Garrett, E., Wiesmann, M., Garcia, P.D., Fuller, J.H., Chan, V., . (2003). beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63, 3145-3153 .
[22] Fanto, M., and McNeill, H. (2004). Planar polarity from flies to vertebrates. J Cell Sci 117, 527-533 .10.1242/jcs.00973
[23] Finch, P.W., He, X., Kelley, M.J., Uren, A., Schaudies, R.P., Popescu, N.C., Rudikoff, S., Aaronson, S.A., Varmus, H.E., and Rubin, J.S. (1997). Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A 94, 6770-6775 .10.1073/pnas.94.13.6770
[24] Furness, M.S., Robinson, T.P., Ehlers, T., Hubbard, R.B. 4th, Arbiser, J.L., Goldsmith, D.J., and Bowen, J.P. (2005). Antiangiogenic agents: studies on fumagillin and curcumin analogs. Curr Pharm Des 11, 357-373 .10.2174/1381612053382142
[25] Gao, G., Shao, C., Zhang, S.X., Dudley, A., Fant, J., and Ma, J.X. (2003). Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia 46, 689-698 .
[26] Gettins, P.G. (2002). Serpin structure, mechanism, and function. Chem Rev 102, 4751-4804 .10.1021/cr010170+
[27] Glinka, A., Wu, W., Delius, H., Monaghan, A.P., Blumenstock, C., and Niehrs, C. (1998). Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391, 357-362 .10.1038/34848
[28] Guo, N., Hawkins, C., and Nathans, J. (2004). Frizzled6 controls hair patterning in mice. Proc Natl Acad Sci U S A 101, 9277-9281 .10.1073/pnas.0402802101
[29] Hanai, J., Gloy, J., Karumanchi, S.A., Kale, S., Tang, J., Hu, G., Chan, B., Ramchandran, R., Jha, V., Sukhatme, V.P., . (2002). Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 158, 529-539 .10.1083/jcb.200203064
[30] He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998). Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 .10.1126/science.281.5382.1509
[31] He, X., Saint-Jeannet, J.P., Wang, Y., Nathans, J., Dawid, I., and Varmus, H. (1997). A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275, 1652-1654 .10.1126/science.275.5306.1652
[32] He, X., Semenov, M., Tamai, K., and Zeng, X. (2004). LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131, 1663-1677 .10.1242/dev.01117
[33] Hoang, B., Moos, M. Jr, Vukicevic, S., and Luyten, F.P. (1996). Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem 271, 26131-26137 .10.1074/jbc.271.42.26131
[34] Howe, L.R., Subbaramaiah, K., Chung, W.J., Dannenberg, A.J., and Brown, A.M. (1999). Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 59, 1572-1577 .
[35] Hsieh, J.C., Kodjabachian, L., Rebbert, M.L., Rattner, A., Smallwood, P.M., Samos, C.H., Nusse, R., Dawid, I.B., and Nathans, J. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398, 431-436 .10.1038/18899
[36] Hu, J., Dong, A., Fernandez-Ruiz, V., Shan, J., Kawa, M., Martínez-Ansó, E., Prieto, J., and Qian, C. (2009). Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 69, 6951-6959 .10.1158/0008-5472.CAN-09-0541
[37] Huang, M.T., Lou, Y.R., Ma, W., Newmark, H.L., Reuhl, K.R., and Conney, A.H. (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841-5847 .
[38] Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R.T., Ninomiya-Tsuji, J., and Matsumoto, K. (2003). The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23, 131-139 .10.1128/MCB.23.1.131-139.2003
[39] Jones, S.E., and Jomary, C. (2002). Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 24, 811-820 .10.1002/bies.10136
[40] Kawano, Y., and Kypta, R. (2003). Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116, 2627-2634 .10.1242/jcs.00623
[41] Kohn, E.C., Alessandro, R., Spoonster, J., Wersto, R.P., and Liotta, L.A. (1995). Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci U S A 92, 1307-1311 .10.1073/pnas.92.5.1307
[42] Krupnik, V.E., Sharp, J.D., Jiang, C., Robison, K., Chickering, T.W., Amaravadi, L., Brown, D.E., Guyot, D., Mays, G., Leiby, K., . (1999). Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313 .
[43] Kühl, M., Sheldahl, L.C., Malbon, C.C., and Moon, R.T. (2000). Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 275, 12701-12711 .10.1074/jbc.275.17.12701
[44] Kühl, M., Sheldahl, L.C., Park, M., Miller, J.R., and Moon, R.T. (2000). The Wnt/Ca²⁺ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16, 279-283 .10.1016/S0168-9525(00)02028-X
[45] Kunnumakkara, A.B., Anand, P., and Aggarwal, B.B. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269, 199-225 .10.1016/j.canlet.2008.03.009
[46] Ladher, R.K., Church, V.L., Allen, S., Robson, L., Abdelfattah, A., Brown, N.A., Hattersley, G., Rosen, V., Luyten, F.P., Dale, L., . (2000). Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. Dev Biol 218, 183-198 .10.1006/dbio.1999.9586
[47] Leow, P.C., Tian, Q., Ong, Z.Y., Yang, Z., and Ee, P.L. (2009). Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest New Drugs . In press.
[48] Leyns, L., Bouwmeester, T., Kim, S.H., Piccolo, S., and De Robertis, E.M. (1997). Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88, 747-756 .
[49] Li, A., Dubey, S., Varney, M.L., Dave, B.J., and Singh, R.K. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170, 3369-3376 .
[50] Li, L., Mao, J., Sun, L., Liu, W., and Wu, D. (2002). Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. J Biol Chem 277, 5977-5981 .10.1074/jbc.M111131200
[51] Lin, K., Wang, S., Julius, M.A., Kitajewski, J., Moos, M. Jr, and Luyten, F.P. (1997). The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A 94, 11196-11200 .10.1073/pnas.94.21.11196
[52] Logan, C.Y., and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781-810 .10.1146/annurev.cellbio.20.010403.113126
[53] Ma, J.X., Yang, Z., Chao, J., and Chao, L. (1995). Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J Biol Chem 270, 451-455 .10.1074/jbc.270.1.451
[54] Mann, B., Gelos, M., Siedow, A., Hanski, M.L., Gratchev, A., Ilyas, M., Bodmer, W.F., Moyer, M.P., Riecken, E.O., Buhr, H.J., . (1999). Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96, 1603-1608 .10.1073/pnas.96.4.1603
[55] Mao, B., and Niehrs, C. (2003). Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302, 179-183 .
[56] Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B.M., Delius, H., Hoppe, D., Stannek, P., Walter, C., . (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417, 664-667 .10.1038/nature756
[57] Mao, B., Wu, W., Li, Y., Hoppe, D., Stannek, P., Glinka, A., and Niehrs, C. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325 .10.1038/35077108
[58] Masckauchán, T.N., Agalliu, D., Vorontchikhina, M., Ahn, A., Parmalee, N.L., Li, C.M., Khoo, A., Tycko, B., Brown, A.M., and Kitajewski, J. (2006). Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell 17, 5163-5172 .10.1091/mbc.E06-04-0320
[59] Masckauchán, T.N., and Kitajewski, J. (2006). Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda) 21, 181-188 .10.1152/physiol.00058.2005
[60] Masckauchán, T.N., Shawber, C.J., Funahashi, Y., Li, C.M., and Kitajewski, J. (2005). Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 8, 43-51 .10.1007/s10456-005-5612-9
[61] Melkonyan, H.S., Chang, W.C., Shapiro, J.P., Mahadevappa, M., Fitzpatrick, P.A., Kiefer, M.C., Tomei, L.D., and Umansky, S.R. (1997). SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A 94, 13636-13641 .10.1073/pnas.94.25.13636
[62] Miao, R.Q., Agata, J., Chao, L., and Chao, J. (2002). Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100, 3245-3252 .10.1182/blood-2002-01-0185
[63] Mlodzik, M. (2002). Planar cell polarization: do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends Genet 18, 564-571 .10.1016/S0168-9525(02)02770-1
[64] Monkley, S.J., Delaney, S.J., Pennisi, D.J., Christiansen, J.H., and Wainwright, B.J. (1996). Targeted disruption of the Wnt2 gene results in placentation defects. Development 122, 3343-3353 .
[65] Muley, A., Majumder, S., Kolluru, G.K., Parkinson, S., Viola, H., Hool, L., Arfuso, F., Ganss, R., Dharmarajan, A., and Chatterjee, S. (2010). Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol 176, 1505-1516 .10.2353/ajpath.2010.090465
[66] Murray, S.R., Chao, J., Lin, F.K., and Chao, L. (1990). Kallikrein multigene families and the regulation of their expression. J Cardiovasc Pharmacol 15, S7-S16 .
[67] Nakamura, T., Tsuchiya, K., and Watanabe, M. (2007). Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision. J Gastroenterol 42, 705-710 .10.1007/s00535-007-2087-z
[68] Nusse, R. (2005). Wnt signaling in disease and in development. Cell Res 15, 28-32 .10.1038/sj.cr.7290260
[69] Nusse, R., van Ooyen, A., Cox, D., Fung, Y.K., and Varmus, H. (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307, 131-136 .10.1038/307131a0
[70] O’Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285 .
[71] Ojesina, A.I. (2004). The role of beta-catenin in regulating angiogenesis in Wilms tumor. J Pediatr Surg 39, 1446-1447 . 10.1016/j.jpedsurg.2004.06.003
[72] Orsulic, S., and Peifer, M. (1996). Cell-cell signalling: Wingless lands at last. Curr Biol 6, 1363-1367 .10.1016/S0960-9822(96)00731-2
[73] Park, C.H., Hahm, E.R., Park, S., Kim, H.K., and Yang, C.H. (2005). The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Lett 579, 2965-2971 .10.1016/j.febslet.2005.04.013
[74] Polakis, P. (2002). Casein kinase 1: a Wnt’er of disconnect. Curr Biol 12, R499-R501 .10.1016/S0960-9822(02)00969-7
[75] Povelones, M., Howes, R., Fish, M., and Nusse, R. (2005). Genetic evidence that Drosophila frizzled controls planar cell polarity and Armadillo signaling by a common mechanism. Genetics 171, 1643-1654 .10.1534/genetics.105.045245
[76] Prieve, M.G., and Moon, R.T. (2003). Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells. BMC Dev Biol 3, 2.10.1186/1471-213X-3-2
[77] Rattner, A., Hsieh, J.C., Smallwood, P.M., Gilbert, D.J., Copeland, N.G., Jenkins, N.A., and Nathans, J. (1997). A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A 94, 2859-2863 .10.1073/pnas.94.7.2859
[78] Rey, J.P., and Ellies, D.L. (2010). Wnt modulators in the biotech pipeline. Dev Dyn 239, 102-114 .10.1002/dvdy.22249
[79] Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., and Nusse, R. (1987). The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50, 649-657 .
[80] Robitaille, J., MacDonald, M.L., Kaykas, A., Sheldahl, L.C., Zeisler, J., Dubé, M.P., Zhang, L.H., Singaraja, R.R., Guernsey, D.L., Zheng, B., . (2002). Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 32, 326-330 .10.1038/ng957
[81] Ryu, M.J., Cho, M., Song, J.Y., Yun, Y.S., Choi, I.W., Kim, D.E., Park, B.S., and Oh, S. (2008). Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 377, 1304-1308 .10.1016/j.bbrc.2008.10.171
[82] Sem?nov, M.V., Tamai, K., Brott, B.K., Kühl, M., Sokol, S., and He, X. (2001). Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11, 951-961 .10.1016/S0960-9822(01)00290-1
[83] Sem?nov, M.V., Zhang, X., and He, X. (2008). DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem 283, 21427-21432 .10.1074/jbc.M800014200
[84] Sharma, R.P., and Chopra, V.L. (1976). Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev Biol 48, 461-465 .10.1016/0012-1606(76)90108-1
[85] Sheldahl, L.C., Park, M., Malbon, C.C., and Moon, R.T. (1999). Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 9, 695-698 .10.1016/S0960-9822(99)80310-8
[86] Shi, Y., He, B., You, L., and Jablons, D.M. (2007). Roles of secreted frizzled-related proteins in cancer. Acta Pharmacol Sin 28, 1499-1504 .10.1111/j.1745-7254.2007.00692.x
[87] Shimokawa, T., Furukawa, Y., Sakai, M., Li, M., Miwa, N., Lin, Y.M., and Nakamura, Y. (2003). Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63, 6116-6120 .
[88] Shu, W., Jiang, Y.Q., Lu, M.M., and Morrisey, E.E. (2002). Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129, 4831-4842 .
[89] Slusarski, D.C., Corces, V.G., and Moon, R.T. (1997). Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390, 410-413 .10.1038/37138
[90] Tachikawa, K., Schr?der, O., Frey, G., Briggs, S.P., and Sera, T. (2004). Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proc Natl Acad Sci U S A 101, 15225-15230 .10.1073/pnas.0406473101
[91] Tetsu, O., and McCormick, F. (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426 .10.1038/18884
[92] Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P.J., and Yang, Y. (2003). Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162, 899-908 .10.1083/jcb.200303158
[93] Umar, S., Sarkar, S., Wang, Y., and Singh, P. (2009). Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin. J Biol Chem 284, 22274-22284 .10.1074/jbc.M109.020941
[94] Uren, A., Reichsman, F., Anest, V., Taylor, W.G., Muraiso, K., Bottaro, D.P., Cumberledge, S., and Rubin, J.S. (2000). Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275, 4374-4382 .10.1074/jbc.275.6.4374
[95] van Amerongen, R., Mikels, A., and Nusse, R. (2008). Alternative wnt signaling is initiated by distinct receptors. Sci Signal 1, re9.10.1126/scisignal.135re9
[96] Varinska, L., Mirossay, L., Mojzisova, G., and Mojzis, J. (2010). Antiangogenic effect of selected phytochemicals. Pharmazie 65, 57-63 .
[97] Wang, S., Krinks, M., Lin, K., Luyten, F.P., and Moos, M. Jr. (1997a). Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 88, 757-766 .
[98] Wang, S., Krinks, M., and Moos, M. Jr. (1997b). Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts-3A, -5A, or-11. Biochem Biophys Res Commun 236, 502-504 .10.1006/bbrc.1997.6995
[99] Wissmann, C., Wild, P.J., Kaiser, S., Roepcke, S., Stoehr, R., Woenckhaus, M., Kristiansen, G., Hsieh, J.C., Hofstaedter, F., Hartmann, A., . (2003). WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201, 204-212 .10.1002/path.1449
[100] Wright, M., Aikawa, M., Szeto, W., and Papkoff, J. (1999). Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun 263, 384-388 .10.1006/bbrc.1999.1344
[101] Wu, W., Glinka, A., Delius, H., and Niehrs, C. (2000). Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 10, 1611-1614 .10.1016/S0960-9822(00)00868-X
[102] Wu, X., Tu, X., Joeng, K.S., Hilton, M.J., Williams, D.A., and Long, F. (2008). Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133, 340-353 .
[103] Xu, Q., D’Amore, P.A., and Sokol, S.Y. (1998). Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist. Development 125, 4767-4776 .
[104] Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P.M., Williams, J., Woods, C., Kelley, M.W., Jiang, L., Tasman, W., Zhang, K., . (2004). Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116, 883-895 .
[105] Yamamoto, H., Sakane, H., Yamamoto, H., Michiue, T., and Kikuchi, A. (2008). Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling. Dev Cell 15, 37-48 .10.1016/j.devcel.2008.04.015
[106] Zerlin, M., Julius, M.A., and Kitajewski, J. (2008). Wnt/Frizzled signaling in angiogenesis. Angiogenesis 11, 63-69 .10.1007/s10456-008-9095-3
[107] Zhang, B., Abreu, J.G., Zhou, K., Chen, Y., Hu, Y., Zhou, T., He, X., and Ma, J.X. (2010a). Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci U S A 107, 6900-6905 .10.1073/pnas.0906764107
[108] Zhang, B., Hu, Y., and Ma, J.X. (2009). Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest Ophthalmol Vis Sci 50, 3943-3952 .10.1167/iovs.08-2954
[109] Zhang, B., Ma, J.X., and Cookson, M.R. (2008). SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS ONE 3, e4077.10.1371/journal.pone.0004077
[110] Zhang, B., Zhou, K.K., and Ma, J.X. (2010b). Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes 59, 1809-1816 .10.2337/db09-1056
[111] Zhang, X., Gaspard, J.P., and Chung, D.C. (2001). Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61, 6050-6054 .